Joseph Stringer Analyst Performance

Senior Analyst at Needham & Company LLC

Joseph Stringer is a stock analyst at Needham & Company LLC in the medical sector, covering 20 publicly traded companies. Over the past year, Joseph Stringer has issued 63 stock ratings, including buy and hold recommendations. While full access to Joseph Stringer's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Joseph Stringer's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 90 Last 4 Years
Buy Recommendations: 87.78% 79 Buy Ratings
Companies Covered: 20 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	87.8%	79 ratings
Hold	12.2%	11 ratings
Sell	0.0%	0 ratings

Out of 90 total stock ratings issued by Joseph Stringer at Needham & Company LLC, the majority (87.8%) have been Buy recommendations, followed by 12.2% Hold.

Best & Worst Calls

Best Call
0000.0%
PLRX
May 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
ANNX
Sep 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	20 companies

Joseph Stringer, an analyst at Needham & Company LLC, currently covers 20 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 20 companies	100.0%

Joseph Stringer of Needham & Company LLC specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 15 companies	75.0%
PHARMACEUTICAL PREPARATIONS 3 companies	15.0%
MED - DRUGS 2 companies	10.0%

About Joseph Stringer

Joseph Stringer joined Needham & Company in 2017, where he covers biotechnology companies. Prior to Needham, Joseph worked as a research scientist at Ra Pharmaceuticals. He conducted postdoctoral work at Yale University, earned his Ph.D. in Chemistry from the University of Wisconsin – Madison, and received a B.S. in Chemistry from Southern Illinois University – Carbondale.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
CDTX Cidara Therapeutics	9/24/2025	Boost Price Target	$87.51	$100.00	Buy
RNA Avidity Biosciences	9/10/2025	Boost Price Target	$46.98	$65.00	Buy
IONS Ionis Pharmaceuticals	9/2/2025	Boost Price Target	$56.47	$70.00	Buy
IONS Ionis Pharmaceuticals	8/25/2025	Reiterated Rating	$42.69	$55.00	Buy
CDTX Cidara Therapeutics	8/8/2025	Reiterated Rating	$61.73	$74.00	Buy
ALNY Alnylam Pharmaceuticals	7/31/2025	Boost Price Target	$393.00	$478.00	Buy
GILD Gilead Sciences	7/25/2025	Upgrade	$113.20	$133.00	Buy
RYTM Rhythm Pharmaceuticals	7/9/2025	Reiterated Rating	$85.44	$95.00	Buy
STOK Stoke Therapeutics	7/1/2025	Reiterated Rating	$11.35	$22.00	Buy
ALNY Alnylam Pharmaceuticals	6/26/2025	Boost Price Target	$321.94	$377.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CDTX Cidara Therapeutics	6/23/2025	Boost Price Target	$40.74	$54.00	Buy
PHAT Phathom Pharmaceuticals	6/6/2025	Reiterated Rating	$9.58	$28.00	Buy
CDTX Cidara Therapeutics	6/4/2025	Boost Price Target	$23.30	$36.00	Buy
CDTX Cidara Therapeutics	5/23/2025	Reiterated Rating	$25.70	$35.00	Buy
VIR Vir Biotechnology	5/22/2025	Reiterated Rating	$4.51	$14.00	Buy
GILD Gilead Sciences	5/21/2025	Reiterated Rating	$109.11		Hold
INZY Inozyme Pharma	5/14/2025	Lower Price Target	$1.28	$12.00	Buy
ANNX Annexon	5/13/2025	Lower Price Target	$1.77	$11.00	Buy
VIR Vir Biotechnology	5/12/2025	Lower Price Target	$5.40	$14.00	Buy
APLS Apellis Pharmaceuticals	5/7/2025	Lower Price Target	$17.78	$29.00	Buy
RYTM Rhythm Pharmaceuticals	5/7/2025	Boost Price Target	$64.90	$72.00	Buy
VRTX Vertex Pharmaceuticals	5/6/2025	Reiterated Rating	$500.19		Hold
IONS Ionis Pharmaceuticals	4/30/2025	Lower Price Target	$30.84	$55.00	Buy
GILD Gilead Sciences	4/25/2025	Reiterated Rating	$106.15		Hold
PHAT Phathom Pharmaceuticals	4/21/2025	Reiterated Rating	$4.03	$28.00	Buy
IONS Ionis Pharmaceuticals	4/15/2025	Reiterated Rating	$28.68	$60.00	Buy
CDTX Cidara Therapeutics	4/10/2025	Reiterated Rating	$17.47	$35.00	Buy
STOK Stoke Therapeutics	4/9/2025	Reiterated Rating	$5.90	$22.00	Buy
RNA Avidity Biosciences	4/9/2025	Reiterated Rating	$24.08	$60.00	Buy
ALNY Alnylam Pharmaceuticals	4/9/2025	Reiterated Rating	$224.32	$320.00	Buy
PHAT Phathom Pharmaceuticals	4/9/2025	Reiterated Rating	$4.25	$28.00	Buy
RYTM Rhythm Pharmaceuticals	4/8/2025	Reiterated Rating	$54.96	$66.00	Buy
PCVX Vaxcyte	4/8/2025	Reiterated Rating	$32.51	$90.00	Buy
IONS Ionis Pharmaceuticals	4/8/2025	Reiterated Rating	$27.57	$60.00	Buy
INZY Inozyme Pharma	4/8/2025	Reiterated Rating	$0.90	$15.00	Buy
PHAT Phathom Pharmaceuticals	4/2/2025	Reiterated Rating	$5.12	$28.00	Buy
PCVX Vaxcyte	4/1/2025	Lower Price Target	$37.76	$90.00	Buy
ALNY Alnylam Pharmaceuticals	3/21/2025	Reiterated Rating	$253.60	$320.00	Buy
RYTM Rhythm Pharmaceuticals	3/18/2025	Boost Price Target	$52.34	$66.00	Buy
STOK Stoke Therapeutics	3/18/2025	Reiterated Rating	$8.67	$22.00	Buy

RNA Avidity Biosciences	3/17/2025	Reiterated Rating	$32.78	$60.00	Buy
INZY Inozyme Pharma	3/11/2025	Lower Price Target	$1.06	$15.00	Buy
CDTX Cidara Therapeutics	3/7/2025	Reiterated Rating	$23.61	$35.00	Buy
PHAT Phathom Pharmaceuticals	3/6/2025	Reiterated Rating	$5.67	$28.00	Buy
ANNX Annexon	3/4/2025	Reiterated Rating	$2.39	$16.00	Buy
PLRX Pliant Therapeutics	3/4/2025	Reiterated Rating	$1.38	$10.00	Hold
LXRX Lexicon Pharmaceuticals	3/3/2025	Reiterated Rating	$0.35		Hold
VIR Vir Biotechnology	2/27/2025	Reiterated Rating	$9.20	$19.00	Buy
RYTM Rhythm Pharmaceuticals	2/27/2025	Reiterated Rating	$53.32	$64.00	Buy
PCVX Vaxcyte	2/26/2025	Reiterated Rating	$79.35	$140.00	Buy
ALNY Alnylam Pharmaceuticals	2/26/2025	Reiterated Rating	$245.20	$320.00	Buy
IONS Ionis Pharmaceuticals	2/20/2025	Reiterated Rating	$31.81	$60.00	Buy
RYTM Rhythm Pharmaceuticals	2/19/2025	Reiterated Rating	$57.55	$64.00	Buy
STOK Stoke Therapeutics	2/18/2025	Reiterated Rating	$9.74	$22.00	Buy
ALNY Alnylam Pharmaceuticals	2/14/2025	Reiterated Rating	$264.89	$320.00	Buy
GILD Gilead Sciences	2/12/2025	Reiterated Rating	$96.14		Hold
PCVX Vaxcyte	2/11/2025	Reiterated Rating	$85.94	$14.00	Buy
VRTX Vertex Pharmaceuticals	2/11/2025	Reiterated Rating	$469.97		Hold
PLRX Pliant Therapeutics	2/10/2025	Lower Price Target	$7.79	$10.00	Buy
VRTX Vertex Pharmaceuticals	1/31/2025	Reiterated Rating	$438.40		Hold
LXRX Lexicon Pharmaceuticals	1/29/2025	Reiterated Rating	$0.93		Hold
ALNY Alnylam Pharmaceuticals	1/13/2025	Reiterated Rating	$237.98	$320.00	Buy
PHAT Phathom Pharmaceuticals	1/10/2025	Reiterated Rating	$6.95	$28.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.